Literature DB >> 15043807

Single Unprovoked Seizures.

Susan T. Herman1.   

Abstract

Unprovoked seizures are common, affecting approximately 4% of the population by age 80. Only approximately 30% to 40% of patients with a first seizure will have a second unprovoked seizure (ie, epilepsy). Treatment with antiepileptic drugs (AEDs) should not be initiated unless the diagnosis of a seizure is firm. Decisions regarding treatment of single unprovoked seizures must balance seizure recurrence risk, the potential impact of a recurrent seizure, the likelihood of adverse effects of treatment, and patient preference. Risk factors for seizure recurrence include a history of remote neurologic insult, epileptiform abnormalities on electroencephalogram, focal structural lesion on neuroimaging, and family history of epilepsy. Adult patients with these risk factors have a recurrence risk of 60% to 70% and usually should be treated with an AED to prevent seizure recurrence. Without risk factors, the recurrence risk is 20% to 30%, and treatment depends on individual risk-to-benefit ratios and patient preference. Treatment of a first unprovoked seizure is often not necessary in childhood, especially if the seizure is part of a benign self-limited syndrome, such as benign Rolandic epilepsy of childhood. Treatment with an AED reduces the risk of seizure recurrence after a single unprovoked seizure. This must be balanced against the risk of adverse effects of AEDs. Treatment of the first seizure does not appear to affect the long-term prognosis of epilepsy. The choice of an AED should be guided by the seizure type and likely epilepsy syndrome diagnosis. Monotherapy is preferable. Standard AED options include phenytoin, carbamazepine, valproate, and phenobarbital. The newer AED, including gabapentin, lamotrigine, topiramate, oxcarbazepine, levetiracetam, and zonisamide, have good efficacy, favorable pharmacokinetic profiles, and often fewer adverse effects, supporting their use early in treatment. Not all of the newer AEDs are approved for use as monotherapy. Patients with single seizures should be counseled about seizure first aid and general safety measures, including precautions regarding swimming alone, engaging in high-risk activities, driving, possible seizure precipitation by photic stimuli (in generalized epilepsy), sleep deprivation, and alcohol.

Entities:  

Year:  2004        PMID: 15043807     DOI: 10.1007/s11940-004-0016-5

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  57 in total

Review 1.  Review of new antiepileptic drugs as initial therapy.

Authors:  Antonio Gil-Nagel
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

2.  Long-term survival of people with unprovoked seizures: a population-based study.

Authors:  E Olafsson; W A Hauser; G Gudmundsson
Journal:  Epilepsia       Date:  1998-01       Impact factor: 5.864

3.  Effectiveness of first antiepileptic drug.

Authors:  P Kwan; M J Brodie
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

4.  Risk of recurrent seizures after two unprovoked seizures.

Authors:  W A Hauser; S S Rich; J R Lee; J F Annegers; V E Anderson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

5.  Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study.

Authors:  S Shinnar; A T Berg; S L Moshé; M Petix; J Maytal; H Kang; E S Goldensohn; W A Hauser
Journal:  Pediatrics       Date:  1990-06       Impact factor: 7.124

6.  A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.

Authors:  F G Gilliam; F Veloso; M A M Bomhof; S K Gazda; V Biton; J P Ter Bruggen; W Neto; C Bailey; G Pledger; S-C Wu
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

7.  Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study.

Authors:  L Forsgren; G Bucht; S Eriksson; L Bergmark
Journal:  Epilepsia       Date:  1996-03       Impact factor: 5.864

8.  Tiagabine monotherapy in the treatment of partial epilepsy.

Authors:  S C Schachter
Journal:  Epilepsia       Date:  1995       Impact factor: 5.864

9.  A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.

Authors:  R H Mattson; J A Cramer; J F Collins
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

10.  Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.

Authors:  Martin J Brodie; David W Chadwick; Henning Anhut; Andreas Otte; Silke-Lo Messmer; Stephen Maton; Wilhelm Sauermann; Guta Murray; Elizabeth A Garofalo
Journal:  Epilepsia       Date:  2002-09       Impact factor: 5.864

View more
  7 in total

1.  Suppression of adult neurogenesis increases the acute effects of kainic acid.

Authors:  Sloka S Iyengar; John J LaFrancois; Daniel Friedman; Liam J Drew; Christine A Denny; Nesha S Burghardt; Melody V Wu; Jenny Hsieh; René Hen; Helen E Scharfman
Journal:  Exp Neurol       Date:  2014-12-02       Impact factor: 5.330

2.  What is the standard approach to assessment of an unprovoked seizure in an adult?: UNITED STATES.

Authors:  Gregory D Cascino
Journal:  Neurol Clin Pract       Date:  2012-12

3.  Using a structured questionnaire improves seizure description by medical students.

Authors:  Saher Kapadia; Hemang Shah; Nancy McNair; J Ned Pruitt; Anthony Murro; Yong Park
Journal:  Int J Med Educ       Date:  2016-01-10

4.  Utility of Magnetic Resonance Imaging Brain Epilepsy Protocol in New-Onset Seizures: How is it Different in Developing Countries?

Authors:  Janardhana Ponnatapura; Suresh Vemanna; Sandeep Ballal; Avisha Singla
Journal:  J Clin Imaging Sci       Date:  2018-11-15

5.  Diagnostic Accuracy of the Ambulatory EEG vs. Routine EEG for First Single Unprovoked Seizures and Seizure Recurrence: The DX-Seizure Study.

Authors:  Lizbeth Hernández-Ronquillo; Lilian Thorpe; Dianne Dash; Tabrez Hussein; Gary Hunter; Karen Waterhouse; Pragma Laboni Roy; Jose F Téllez-Zenteno
Journal:  Front Neurol       Date:  2020-04-09       Impact factor: 4.003

6.  SOP: First-ever epileptic seizure in adult patients.

Authors:  Julian Bösel
Journal:  Neurol Res Pract       Date:  2019-02-28

7.  Predictors of Poor Seizure Control in Children Managed at a Tertiary Care Hospital of Eastern Nepal.

Authors:  Prakash Poudel; Mohit Chitlangia; Rita Pokharel
Journal:  Iran J Child Neurol       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.